83 FR 40775 - Meeting of the National Vaccine Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 159 (August 16, 2018)

Page Range		40775-40776
FR Document		2018-17618

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that a meeting is scheduled to be held for the National Vaccine Advisory Committee (NVAC). The meeting will be open to the public; public comment sessions will be held during the meeting.

Federal Register, Volume 83 Issue 159 (Thursday, August 16, 2018)

[Federal Register Volume 83, Number 159 (Thursday, August 16, 2018)]
[Notices]
[Pages 40775-40776]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-17618]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services is hereby giving notice that a 
meeting is scheduled to be held for the National Vaccine Advisory 
Committee (NVAC). The meeting will be open to the public; public 
comment sessions will be held during the meeting.

DATES: The meeting will be held on September 12 and 13, 2018. The 
meeting times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become 
available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Room 800, 200 Independence Avenue SW, Washington, DC 
20201. The meeting can also be accessed through a live webcast on both 
days of the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/index.html.
    Pre-registration is required for members of the public who wish to 
attend the meeting and who wish to participate in a public comment 
session. Individuals who wish to attend the meeting and/or participate 
in a public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/index.html. Participants may also register by emailing 
[email protected] or by calling (202) 690-5566 and providing their name, 
organization, and email address.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, National Vaccine Program Office, U.S. Department of Health and 
Human Services, Room 715H, Hubert H. Humphrey Building, 200 
Independence Avenue SW, Washington, DC 20201. Phone: (202) 690-5566; 
email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program. During the September 2018 NVAC meeting, sessions will consist 
of presentations on valuing vaccines, including presentations on the 
role of vaccines in combatting antibiotic resistance; vaccine 
innovation, including presentations on financing, new technologies, and 
development of new vaccines; lessons from the field, with focus on 
Ebola and the new Shingles vaccine; and a session on HPV vaccination 
for cancer prevention. Please note that agenda items will be related to 
the charge of the Committee and are subject to change as priorities 
dictate. Information on the final meeting agenda will be posted prior 
to the meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend in person and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations,

[[Page 40776]]

should notify the National Vaccine Program Office at the address/phone 
number listed above at least one week prior to the meeting. For those 
unable to attend in person, a live webcast will be available. More 
information on registration and accessing the webcast can be found at 
http://www.hhs.gov/nvpo/nvac/meetings/index.html.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office ([email protected]) at least five 
business days prior to the meeting.

    Dated: July 31, 2018.
Roula K. Sweis,
Chief of Management and Operations, National Vaccine Program Office.
[FR Doc. 2018-17618 Filed 8-15-18; 8:45 am]
 BILLING CODE 4150-44-P

40776 Federal Register / Vol. 83, No. 159 / Thursday, August 16, 2018 / Notices

should notify the National Vaccine Contact Person: Zhuqing (Charlie) Li, Contact Person: Alicia J. Dombroski, Ph.D.,
Program Office at the address/phone Ph.D., Scientific Review Officer, Scientific Director, Division of Extramural Activities,
number listed above at least one week Review Program, Division of Extramural National Institute of Dental & Craniofacial
Activities, Room #3G41B, National Institutes Research, National Institutes of Health,
prior to the meeting. For those unable to
of Health/NIAID, 5601 Fishers Lane, Bethesda, MD 20892, 301–594–4805,
attend in person, a live webcast will be MSC9823, Bethesda, MD 20892–9823, (240) adombroski@nidcr.nih.gov.
available. More information on 669–5068, zhuqing.li@nih.gov. In the interest of security, NIH has
registration and accessing the webcast instituted stringent procedures for entrance
(Catalogue of Federal Domestic Assistance
can be found at http://www.hhs.gov/ Program Nos. 93.855, Allergy, Immunology, onto the NIH campus. All visitor vehicles,
nvpo/nvac/meetings/index.html. and Transplantation Research; 93.856, including taxicabs, hotel, and airport shuttles
Members of the public will have the Microbiology and Infectious Diseases will be inspected before being allowed on
opportunity to provide comments at the Research, National Institutes of Health, HHS) campus. Visitors will be asked to show one
NVAC meeting during the public form of identification (for example, a
Dated: August 10, 2018. government-issued photo ID, driver’s license,
comment periods designated on the
agenda. Public comments made during Natasha M. Copeland, or passport) and to state the purpose of their
the meeting will be limited to three Program Analyst, Office of Federal Advisory visit.
Committee Policy. Information is also available on the
minutes per person to ensure time is Institute’s/Center’s home page: http://
allotted for all those wishing to speak. [FR Doc. 2018–17676 Filed 8–15–18; 8:45 am]
www.nidcr.nih.gov/about, where an agenda
Individuals are also welcome to submit BILLING CODE 4140–01–P
and any additional information for the
their written comments. Written meeting will be posted when available.
comments should not exceed three (Catalogue of Federal Domestic Assistance
pages in length. Individuals submitting DEPARTMENT OF HEALTH AND
Program Nos. 93.121, Oral Diseases and
written comments should email their HUMAN SERVICES Disorders Research, National Institutes of
comments to the National Vaccine National Institutes of Health
Health, HHS)
Program Office (nvpo@hhs.gov) at least Dated: August 10, 2018.
five business days prior to the meeting. National Institute of Dental and Natasha M. Copeland,
Dated: July 31, 2018. Craniofacial Research; Notice of Program Analyst, Office of Federal Advisory
Roula K. Sweis, Meeting Committee Policy.
Chief of Management and Operations, [FR Doc. 2018–17679 Filed 8–15–18; 8:45 am]
National Vaccine Program Office. Pursuant to section 10(d) of the
BILLING CODE 4140–01–P
[FR Doc. 2018–17618 Filed 8–15–18; 8:45 am]
Federal Advisory Committee Act, as
amended, notice is hereby given of a
BILLING CODE 4150–44–P
meeting of the National Advisory Dental DEPARTMENT OF HEALTH AND
and Craniofacial Research Council. HUMAN SERVICES
DEPARTMENT OF HEALTH AND The meeting will be open to the
HUMAN SERVICES public as indicated below, with National Institutes of Health
attendance limited to space available.
National Institutes of Health Individuals who plan to attend and National Institute on Drug Abuse;
need special assistance, such as sign Notice of Closed Meeting
National Institute of Allergy and language interpretation or other
Infectious Diseases; Notice of Closed Pursuant to section 10(d) of the
reasonable accommodations, should Federal Advisory Committee Act, as
Meeting notify the Contact Person listed below amended, notice is hereby given of the
Pursuant to section 10(d) of the in advance of the meeting. following meeting.
Federal Advisory Committee Act, as The meeting will be closed to the The meeting will be closed to the
amended, notice is hereby given of the public in accordance with the public in accordance with the
following meeting. provisions set forth in sections provisions set forth in sections
The meeting will be closed to the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
public in accordance with the as amended. The grant applications and as amended. The contract proposals and
provisions set forth in sections the discussions could disclose the discussions could disclose
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., confidential trade secrets or commercial confidential trade secrets or commercial
as amended. The grant applications and property such as patentable material, property such as patentable material,
the discussions could disclose and personal information concerning and personal information concerning
confidential trade secrets or commercial individuals associated with the grant individuals associated with the contract
property such as patentable material, applications, the disclosure of which proposals, the disclosure of which
and personal information concerning would constitute a clearly unwarranted would constitute a clearly unwarranted
individuals associated with the grant invasion of personal privacy. invasion of personal privacy.
applications, the disclosure of which Name of Committee: National Advisory Name of Committee: National Institute on
would constitute a clearly unwarranted Dental and Craniofacial Research Council. Drug Abuse Special Emphasis Panel;
invasion of personal privacy. Date: September 13, 2018. Analytical Services Center for Medications
Name of Committee: National Institute of Open: 8:30 a.m. to 12:30 p.m. Development (8938).
Allergy and Infectious Diseases Special Agenda: Report to the Director, NIDCR. Date: September 25, 2018.
Place: National Institutes of Health Time: 10:00 a.m. to 12:00 p.m.
sradovich on DSK3GMQ082PROD with NOTICES

Emphasis Panel; NIAID Clinical Trial
Planning Grant (R34). Building 35, Room 620/630, 35 Convent Agenda: To review and evaluate contract
Date: September 10, 2018. Drive, Bethesda, MD 20892. proposals.
Time: 1:00 p.m. to 3:00 p.m. Closed: 1:30 p.m. to 3:00 p.m. Place: National Institutes of Health,
Agenda: To review and evaluate grant Agenda: To review and evaluate grant Neuroscience Center, 6001 Executive
applications. applications and/or proposals. Boulevard, Rockville, MD 20852 (Telephone
Place: National Institutes of Health, 5601 Place: National Institutes of Health, Conference Call).
Fishers Lane, Rockville, MD 20892 Building 35, Room 620/630, 35 Convent Contact Person: Lyle Furr, Scientific
(Telephone Conference Call). Drive, Bethesda, MD 20892. Review Officer, Office of Extramural Affairs,

VerDate Sep<11>2014 17:15 Aug 15, 2018 Jkt 244001 PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 E:\FR\FM\16AUN1.SGM 16AUN1

Document Created: 2018-08-16 01:01:58
Document Modified: 2018-08-16 01:01:58

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		The meeting will be held on September 12 and 13, 2018. The meeting times and agenda will be posted on the NVAC website at http:// www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become available.
Contact		Ann Aikin, Acting Designated Federal Officer, National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]
FR Citation		83 FR 40775